U.S. flag

An official website of the United States government

NM_005373.3(MPL):c.305G>A (p.Arg102His) AND multiple conditions

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jan 26, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001880205.5

Allele description [Variation Report for NM_005373.3(MPL):c.305G>A (p.Arg102His)]

NM_005373.3(MPL):c.305G>A (p.Arg102His)

Gene:
MPL:MPL proto-oncogene, thrombopoietin receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p34.2
Genomic location:
Preferred name:
NM_005373.3(MPL):c.305G>A (p.Arg102His)
HGVS:
  • NC_000001.11:g.43338634G>A
  • NG_007525.1:g.5831G>A
  • NM_005373.3:c.305G>AMANE SELECT
  • NP_005364.1:p.Arg102His
  • LRG_510t1:c.305G>A
  • LRG_510:g.5831G>A
  • NC_000001.10:g.43804305G>A
  • NM_005373.2:c.305G>A
Protein change:
R102H
Links:
dbSNP: rs28928907
NCBI 1000 Genomes Browser:
rs28928907
Molecular consequence:
  • NM_005373.3:c.305G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Congenital amegakaryocytic thrombocytopenia
Identifiers:
MONDO: MONDO:0800451; MedGen: C1327915; Orphanet: 3319; OMIM: PS604498
Name:
Essential thrombocythemia
Synonyms:
essential thrombocytemia; Suspected essential thromboythemia
Identifiers:
MONDO: MONDO:0005029; MeSH: D013920; MedGen: C0040028

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002267966Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Jan 26, 2024)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients.

Germeshausen M, Ballmaier M.

Haematologica. 2021 Sep 1;106(9):2439-2448. doi: 10.3324/haematol.2020.257972.

PubMed [citation]
PMID:
32703794
PMCID:
PMC8409039

Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia.

van den Oudenrijn S, Bruin M, Folman CC, Bussel J, de Haas M, von dem Borne AE.

Br J Haematol. 2002 May;117(2):390-8.

PubMed [citation]
PMID:
11972523
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002267966.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 102 of the MPL protein (p.Arg102His). This variant is present in population databases (no rsID available, gnomAD 0.002%). This missense change has been observed in individual(s) with autosomal recessive congenital amegakaryocytic thrombocytopenia (PMID: 32703794). ClinVar contains an entry for this variant (Variation ID: 988868). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MPL protein function. This variant disrupts the p.Arg102 amino acid residue in MPL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11972523, 16470591, 21659346, 28859041). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024